Literature DB >> 7128634

Exchange transfusion in acute episodes of maple syrup urine disease. Studies on branched-chain amino and keto acids.

U Wendel, U Langenbeck, I Lombeck, H J Bremer.   

Abstract

Two neonates with maple syrup urine disease were treated by exchange transfusion. Within 15 h blood leucine and KICA concentrations were lowered from 2.6 mM to 1.1 mM using 570 to 620 ml blood per kg body weight. The other branched-chain amino acid/keto acid pairs fell to normal. During exchange transfusion the patient's nitrogen balance seems to be negative. Further exchange transfusion was useless. More importantly the patient should be forced into an anabolic state by high caloric supply or insulin plus glucose treatment. More KICA than leucine was eliminated, however, KICA blood levels remained slightly higher than that of leucine indicating different leucine/KICA equilibria in extravascular compartments than in blood. In a given time interval exchange transfusion was more effective than peritoneal dialysis, probably due to a lack of an additional (peritoneal) membrane. Renal excretion of branched-chain amino and keto acids was very inefficient. The allegedly most toxic metabolite, KICA, had the lowest renal clearance of the branched-chain keto acids.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7128634     DOI: 10.1007/bf00442499

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  4 in total

1.  Peritoneal dialysis in maple-syrup-urine disease: studies on branched-chain amino and keto acids.

Authors:  U Wendel; K Becker; H Przyrembel; M Bulla; C Manegold; A Mench-Hoinowski; U Langenbeck
Journal:  Eur J Pediatr       Date:  1980-06       Impact factor: 3.183

2.  Maple syrup urine disease: treatment of the acutely ill newborn.

Authors:  G Hammersen; L Wille; H Schmidt; P Lutz; H Bickel
Journal:  Eur J Pediatr       Date:  1978-10-12       Impact factor: 3.183

3.  Correlations between branched-chain amino acids and branched-chain alpha-keto acids in blood in maple syrup urine disease.

Authors:  U Langenbeck; U Wendel; A Mench-Hoinowski; D Kuschel; K Becker; H Przyrembel; H J Bremer
Journal:  Clin Chim Acta       Date:  1978-09-01       Impact factor: 3.786

4.  Outcome of early and long-term management of classical maple syrup urine disease.

Authors:  C L Clow; T M Reade; C R Scriver
Journal:  Pediatrics       Date:  1981-12       Impact factor: 7.124

  4 in total
  6 in total

1.  The early detection and management of inborn errors presenting acutely in the neonatal period.

Authors:  J V Leonard
Journal:  Eur J Pediatr       Date:  1985-03       Impact factor: 3.183

2.  Organic acids and branched-chain amino acids in body fluids before and after multiple exchange transfusions in maple syrup urine disease.

Authors:  Y Shigematsu; K Kikuchi; T Momoi; M Sudo; Y Kikawa; K Nosaka; M Kuriyama; S Haruki; K Sanada; N Hamano
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

3.  Hudson memorial lecture. Neonatal management of organic acidurias. Clinical update.

Authors:  J M Saudubray; H Ogier; C Charpentier; E Depondt; F X Coudé; A Munnich; G Mitchell; F Rey; J Rey; J Frézal
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

Review 4.  Animal models of maple syrup urine disease.

Authors:  K J Skvorak
Journal:  J Inherit Metab Dis       Date:  2009-03-09       Impact factor: 4.982

5.  Maple syrup urine disease--therapeutic use of insulin in catabolic states.

Authors:  U Wendel; U Langenbeck; I Lombeck; H J Bremer
Journal:  Eur J Pediatr       Date:  1982-11       Impact factor: 3.183

6.  Acute hemodialysis for hyperammonemia in small neonates.

Authors:  Deepak K Rajpoot; John J Gargus
Journal:  Pediatr Nephrol       Date:  2004-03-02       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.